Casgevy

Indicated For

Sickle cell disease, Beta thalassemia

About This Medication

# Vertex Connects Patient Guide: How to Get Casgevy at Low or No Cost Casgevy (exagamglogene autotemcel) is a groundbreaking gene therapy for certain patients with sickle cell disease or beta thalassemia, and **Vertex Connects** from Vertex Pharmaceuticals offers patient support to help access it at low or no cost, regardless of insurance status.[1] This guide explains eligibility, application steps, and more in simple terms to empower you on your treatment journey. ## About Casgevy and Why Assistance Matters **Casgevy** is an FDA-approved one-time gene therapy that edits a patient's own blood stem cells to produce functional hemoglobin, potentially providing long-term relief from sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT).[1] Unlike daily pills or infusions, Casgevy involves a complex process: stem cell collection (aphersis), chemotherapy conditioning, and hospital infusion of edited cells, followed by recovery. The treatment costs hundreds of thousands of dollars, making financial assistance crucial. **Vertex Connects** provides comprehensive support once prescribed, including help with insurance navigation, copay assistance, free drug for uninsured/underinsured, and logistics for this hospital-administered therapy.[1] It's designed for patients like you who need this life-changing option without financial barriers. ## Who Qualifies for Vertex Connects? Eligibility is broad and needs-based, focusing on financial situation rather than strict cutoffs.[1] You may qualify if: - You have a valid Casgevy prescription from your doctor. - You're commercially insured, Medicare/Medicaid eligible, underinsured, or uninsured.[1] - Your income makes affording treatment challenging (specific thresholds assessed case-by-case; no fixed limits listed).[1] **No prior coverage is required**, and enrollment determines tailored support like copay cards or free product.[1] It's not mandatory to enroll to receive Casgevy, but it unlocks key benefits. ## Income Eligibility Breakdown Vertex Connects is **needs-based** without published income thresholds, meaning they evaluate household income, expenses, and insurance holistically.[1] Here's a general guide based on similar programs (exact details via phone): | Household Size | Typical Low-Income Threshold (300-400% FPL) | Notes | |---------------|---------------------------------------------|-------| | 1 | $45,000 - $60,000 | Assessed individually[1] | | 2 | $60,000 - $80,000 | Includes debts/medical costs | | 3 | $75,000 - $100,000 | No hard caps; call for yours | | 4+ | $90,000+ | Larger families often qualify | Contact the program for your personalized assessment—no documents needed upfront.[1] ## Insurance Requirements Flexible options cover most scenarios:[1] - **Commercially insured**: Copay assistance to reduce out-of-pocket costs. - **Medicare/Medicaid**: Bridge programs or free drug if gaps exist. - **Underinsured/Uninsured**: Potential free Casgevy supply.[1] - **No coverage required** for enrollment, but insurance helps speed approval.[1] The program navigates prior authorizations and appeals, ensuring hospital delivery. ## Step-by-Step Application Process 1. **Get Prescribed**: Discuss Casgevy with your hematologist; they initiate once eligible clinically. 2. **Call to Enroll**: Dial **(833) 837-8395** (Mon-Fri, 8 AM-8 PM ET) with your doctor's office.[1] No online form—phone-based for personalized help. 3. **Complete Enrollment Form**: Provided after call; includes basic info on insurance/income (simple, 1-page).[1] 4. **Eligibility Review**: Team assesses needs and matches offerings (e.g., copay, free drug). 5. **Benefits Start**: Support activates pre-infusion; track via patient portal if offered. Your coordinator handles everything—expect a call back within days.[1] ## Timeline and Delivery **Processing**: Varies by insurance; 1-4 weeks for approval post-enrollment.[1] Complex gene therapy means prior auths take time. **Delivery**: **Hospital-administered infusion** only—not shipped home.[1] Steps: - Outpatient apheresis (stem collection). - Lab editing (4-6 weeks). - Inpatient conditioning chemo and infusion. - Recovery (weeks in hospital, months outpatient). Vertex Connects coordinates with your center for seamless logistics. ## Alternatives if Denied or Ineligible - **Appeal**: Program assists with insurance appeals.[1] - **Other Foundations**: Co-pay relief orgs like PAN Foundation or Patient Access Network. - **Clinical Trials**: Ongoing Casgevy studies via ClinicalTrials.gov. - **Biosimilars**: None yet; Casgevy is unique gene therapy.[1] - **State Programs**: Medicaid expansions for SCD/TDT. Discuss with your doctor; Vertex may offer exceptions. ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026 and is not medical/financial advice.[1] Eligibility, benefits, and terms can change—**always call (833) 837-8395** for current info. Consult your healthcare provider for treatment suitability. Vertex Pharmaceuticals reserves rights to modify program anytime. Word count: 912.

Program information last verified: March 30, 2026